Oncology Therapeutics Network and CancerEducation.comto Provide First Full Service Online Oncology Drug Distribution andInformation Solution.
NEW YORK--(BUSINESS WIRE)--Oct. 19, 1999--
Oncology Therapeutics Network (OTN), a wholly-owned subsidiary of Bristol-Myers Squibb (NYSE:BMY), and CancerEducation.com www.cancereducation.com today announced a business alliance that will link their websites to provide medical professionals with the first fully-integrated, comprehensive on-line source for oncology pharmaceuticals, education and information. OTN's complete and convenient oncology drug ordering system will be directly linked to CancerEducation.com's web site for the exclusive provision of cancer-related educational presentations and extensive informational services for oncology professionals. OTN will also become CancerEducation.com's exclusive oncology pharmaceutical ordering and distribution channel, focusing on the supply and service needs of office-based oncologists. In addition, the Companies are exploring additional e-commerce opportunities for collaboration.
"Our mission has always been to support office-based oncologists in their effort to effectively and efficiently offer cancer patients the best possible care," said Tom Ludlam, President of OTN. "Over the last year, it has become increasingly apparent that office-based oncologists are under tremendous time constraints from increased caseloads making it ever more difficult to stay abreast of the latest treatment modalities and diagnostic procedures. By partnering with CancerEducation.com we are able to provide convenient access to up-to-the-minute information and educational programming, as well as other resources and tools customized for the oncology professional. CancerEducation.com, with its disease-specific focus, special understanding of the oncology marketplace and proprietary streaming video educational content, was clearly the best fit for OTN and our customers."
Michael S. Weiss, CEO of CancerEducation.com, said, "OTN's leadership position in the oncology marketplace, dedication to customer service and the clear technical superiority of OTN's web-based drug distribution solution over competitive systems made OTN the perfect partner." Weiss continued, "OTN's on-line drug ordering system is user-friendly, yet highly sophisticated, and OTN continues to set the standard for cost containment and customer service. Together we can provide office-based oncologists with the most complete choice of pharmaceuticals and the latest information they need to deliver the very best patient care."
